Obesity and insulin resistance increase plasma viscosity in young women with polycystic ovary syndrome

Objective. To investigate the plasma viscosity in young women with polycystic ovary syndrome (PCOS). Design. Patients with PCOS and healthy controls were assessed for plasma viscosity. The acquired data were tested for association with hyperandrogenemia, obesity and insulin resistance (IR) in patien...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gynecological endocrinology 2009-01, Vol.25 (10), p.640-646
Hauptverfasser: Vervita, Vasiliki, Saltamavros, Alexandros D., Adonakis, George, Tsapanos, Vasilios, Decavalas, George, Georgopoulos, Neoklis A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective. To investigate the plasma viscosity in young women with polycystic ovary syndrome (PCOS). Design. Patients with PCOS and healthy controls were assessed for plasma viscosity. The acquired data were tested for association with hyperandrogenemia, obesity and insulin resistance (IR) in patients with PCOS. Plasma viscosity was determined by a viscometer Type 53610 I SCHOTT-Instruments, Mainz at 37°C. Patients. The study included 96 young women with PCOS and 72 healthy controls. Main outcome measures. Plasma viscosity and IR. Results. Plasma viscosity was 1.243 ± 0.67 mm2 s in the control group and 1.252 ± 0.82 in women with PCOS (p = 0.416). Using multiple regression analysis, total protein (B = 0.348, p = 0.005), area under curve for insulin (B = 0.320, p = 0.011) and BMI (B = 0.315, p = 0.013) were proven to be significantly correlated to plasma viscosity. Plasma viscosity was significantly increased in women with PCOS with IR compared to matched for age and BMI PCOS women without IR (1.300 ± 0.055 vs. 1.231 ± 0.049 mm2 s) (p = 0.004). Conclusion. Young women with PCOS presented a plasma viscosity that was increased by obesity and IR. Therefore, clinical management of young overweight women with PCOS with IR should always include a serious reduction in body weight and the use of oral contraceptive treatment with cautious.
ISSN:0951-3590
1473-0766
DOI:10.1080/09513590903015486